RABS / Isolator (if used) – Validation Summary Report (VSR) Template

Validation Summary Report (VSR)

Summary

This Validation Summary Report (VSR) documents the validation activities for the RABS / Isolator used in the production of sterile eye drops and eye ointments. The report encompasses the Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) phases.

Scope/Boundaries

The scope of this validation report includes the RABS / Isolator system utilized in the production area for ophthalmic products. The boundaries of this report are defined by the URS Annex 1 and Annex 11 guidelines, ensuring compliance with regulatory standards for sterile manufacturing.

Executed Protocol List

  • Design Qualification (DQ) Protocol
  • Installation Qualification (IQ) Protocol
  • Operational Qualification (OQ) Protocol
  • Performance Qualification (PQ) Protocol

Deviations Summary

All deviations encountered during the validation process have been documented and addressed. No critical deviations were reported that would impact the integrity of the validation outcomes.

CPP Verification Summary

The key critical parameters for the RABS / Isolator system include:

  • Leak integrity
  • Glove integrity
  • VHP cycle logs

All critical parameters were verified and met the acceptance criteria as outlined in the URS Annex 1 and Annex 11.

Conclusion

Based on the executed protocols and the verification of critical parameters, it is concluded that the RABS / Isolator system is validated for use in the production of sterile eye drops and eye ointments. The system is compliant with the relevant regulatory guidelines and is approved for routine use.

Attachments Index

  • Attachment 1: DQ Protocol Document
  • Attachment 2: IQ Protocol Document
  • Attachment 3: OQ Protocol Document
  • Attachment 4: PQ Protocol Document
  • Attachment 5: Deviations Log
  • Attachment 6: CPP Verification Records
See also  Colloid Mill (if used) – Deviation Impact Assessment

Approvals

This Validation Summary Report has been reviewed and approved by the following personnel:

  • Quality Assurance Manager: [Name]
  • Validation Lead: [Name]
  • Production Manager: [Name]

Requalification Frequency: 12 Months